mondoBIOTECH™

physicians
investors
media
community

February 03, 2010

Lung Rx LLC, a subsidiary of United Therapeutics Corporation (NASDAQ: UTHR), and mondoBIOTECH holding AG (SIX: RARE) announce today a global strategic partnership agreement for the development of Aviptadil platform.

January 27, 2010

mondoBIOTECH Holding AG (SIX: RARE) today announces the first medical product candidate against Extensively Drug-Resistant Tuberculosis (XDR-TB)

January 25, 2010

mondoBIOTECH holding AG: the Board of Directors has set the final terms of its planned capital increase

January 25, 2010

mondoBIOTECH holding AG: interim financial results for Q3 2009

January 15, 2010

mondoBIOTECH holding AG: the extraordinary shareholders' meeting approves all of the Board of Directors’ proposals

Fabio Cavalli
CEO Mondobiotech
0:36 min (english)

Thomas Cerny
Head of Oncology, President of the Swiss Cancer League and Member
of the Board of Mondobiotech
1:30 min (english)

2010